Featuring how libraries can support Plan S implementation, the Incentivization Blueprint encouraging funders to align with the principles of open research, and the effect on citation performance of a journal becoming open access.
Featuring the release of the Foundations for Open Scholarship Strategy Development document, the addition of citation data to Altmetric, the launch of Participation Reports by Crossref, and The Francis Crick Institute’s commitment to open access and preprints.
Featuring the launch of cloud-based technology that enables one-click access to research articles, the new supplement for publishing negative results, and the first publisher-owned open research platform.
Open access publishing of medical research is increasingly prevalent, but open access terminology is varied and confusing. Gold, green, bronze, hybrid, CC BY, CC BY-NC – what does it all mean, and what is the best type of open access? At the 14th Annual Meeting of the International Society of Medical Publication Professionals, a panel of stakeholders in medical publications met to discuss open access from different perspectives.
Featuring the plans of UK research funders to review their open access policies, indications that the EU is set to miss its open access target, blockchain technologies for peer review, and a new preprints highlighting service.
Featuring the EU Commission’s new open science role, a new tool to analyse the uptake of hybrid open access publishing, and results from the European University Association’s open access survey.
Featuring Vivli, a novel global clinical trial data sharing platform, MedArXiv, the preprint server for medicine, the BMJ’s new open access journal and the peer review distribution index.
Featuring an introduction to Metadata2020, reaction to proposals for EU copyright reform, Elsevier’s new data-sharing framework and initial decisions on the second Research Excellence Framework.
Use of preprints is increasing rapidly, with the number of preprints posted to repositories each month almost doubling in the past year
Summary report from the Open Pharma workstream meetings in July